Max O. Meneveau
- Oncology top 10%
- Immunology top 10%
- Surgery
- Molecular Biology
- Cancer Research
- Co-authors
- Craig L. SlingluffSamuel YoungIleana S. MauldinJ. Hunter MehaffeyVíctor H. EngelhardKevin LynchAlex D. MichaelsMarit M. Melssen
- Topics
- Cancer Immunotherapy and Biomarkers (10 papers)Immunotherapy and Immune Responses (9 papers)Breast Cancer Treatment Studies (8 papers)
- Cited by
- ImmunologyOncologyCancer Research
- Partner nations
- United StatesSwedenNetherlands
In The Last Decade
Max O. Meneveau
32 papers receiving 641 citations
Peers
Comparison fields: 5 of 90
- Oncology 318
- Immunology 269
- Surgery 140
- Molecular Biology 68
- Cancer Research 60
Countries citing papers authored by Max O. Meneveau
This map shows the geographic impact of Max O. Meneveau's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Max O. Meneveau with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Max O. Meneveau more than expected).
Fields of papers citing papers by Max O. Meneveau
This network shows the impact of papers produced by Max O. Meneveau. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Max O. Meneveau. The network helps show where Max O. Meneveau may publish in the future.
Co-authorship network of co-authors of Max O. Meneveau
This figure shows the co-authorship network connecting the top 25 collaborators of Max O. Meneveau. A scholar is included among the top collaborators of Max O. Meneveau based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Max O. Meneveau. Max O. Meneveau is excluded from the visualization to improve readability, since they are connected to all nodes in the network.
All Works
| # | Work | Indexed citations |
|---|---|---|
| 1 | 0 | |
| 2 | 0 | |
| 3 | 14 | |
| 4 | 1 | |
| 5 | 1 | |
| 6 | 1 | |
| 7 | 14 | |
| 8 | 9 | |
| 9 | 19 | |
| 10 | 54 | |
| 11 | 47 | |
| 12 | 16 | |
| 13 | 10 | |
| 14 | 23 | |
| 15 | 11 | |
| 16 | 5 | |
| 17 | 11 | |
| 18 | 2 | |
| 19 | 43 | |
| 20 | 16 |
About Max O. Meneveau
Max O. Meneveau is a scholar working on Oncology, Cancer Research and Immunology, having authored 35 papers that have together received 647 indexed citations. Recurring topics across this work include Cancer Immunotherapy and Biomarkers (10 papers), Immunotherapy and Immune Responses (9 papers) and Breast Cancer Treatment Studies (8 papers). The work is most often cited by research in Immunology (269 citations), Oncology (318 citations) and Cancer Research (60 citations). Max O. Meneveau has collaborated with scholars based in United States, Sweden and Netherlands. Frequent co-authors include Craig L. Slingluff, Samuel Young, Ileana S. Mauldin, J. Hunter Mehaffey, Víctor H. Engelhard, Kevin Lynch, Alex D. Michaels, Marit M. Melssen, Shayna L. Showalter and Robert B. Hawkins. Their work appears in journals such as Annals of Surgery, International Journal of Cancer and Cell Reports.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.